| 000 | 01042 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516064652.0 | ||
| 264 | 0 | _c20120514 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1873-4286 | ||
| 024 | 7 |
_a10.2174/138161211798357890 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWolanczyk-Medrala, Anna | |
| 245 | 0 | 0 |
_aCD164 as a Basophil Activation Marker. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _cNov 2011 |
||
| 300 |
_a3786-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBasophils _ximmunology |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aEndolyn _xbiosynthesis |
| 650 | 0 | 4 |
_aFlow Cytometry _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypersensitivity _xblood |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aBarg, Wojciech | |
| 700 | 1 | _aMedrala, Wojciech | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 17 _gno. 34 _gp. 3786-96 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/138161211798357890 _zAvailable from publisher's website |
| 999 |
_c21330962 _d21330962 |
||